KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Cash from Financing Activities (2020 - 2025)

Historic Cash from Financing Activities for Oscar Health (OSCR) over the last 6 years, with Q4 2025 value amounting to $8.2 million.

  • Oscar Health's Cash from Financing Activities rose 11406.86% to $8.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $399.2 million, marking a year-over-year increase of 48374.42%. This contributed to the annual value of $399.2 million for FY2025, which is 48374.42% up from last year.
  • As of Q4 2025, Oscar Health's Cash from Financing Activities stood at $8.2 million, which was up 11406.86% from $364.0 million recorded in Q3 2025.
  • In the past 5 years, Oscar Health's Cash from Financing Activities registered a high of $1.2 billion during Q1 2021, and its lowest value of $423000.0 during Q3 2022.
  • For the 5-year period, Oscar Health's Cash from Financing Activities averaged around $100.7 million, with its median value being $6.5 million (2025).
  • Per our database at Business Quant, Oscar Health's Cash from Financing Activities skyrocketed by 27400633.48% in 2021 and then plummeted by 9983.06% in 2023.
  • Over the past 5 years, Oscar Health's Cash from Financing Activities (Quarter) stood at $13.0 million in 2021, then tumbled by 95.94% to $527000.0 in 2022, then skyrocketed by 102.85% to $1.1 million in 2023, then surged by 257.06% to $3.8 million in 2024, then skyrocketed by 114.07% to $8.2 million in 2025.
  • Its Cash from Financing Activities was $8.2 million in Q4 2025, compared to $364.0 million in Q3 2025 and $22.1 million in Q2 2025.